Behavioural supersensitivity to apomorphine following chronic treatment with drugs which interfere with the synaptic function of catecholamines.
D000818:Animals; D001058:Apomorphine / Q000494:pharmacology*; D001522:Behavior, Animal / Q000187:drug effects*; D001835:Body Weight / Q000187:drug effects; D002395:Catecholamines / Q000037:antagonists & inhibitors*; D002746:Chlorpromazine / Q000494:pharmacology; D003975:Diazepam / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D006220:Haloperidol / Q000494:pharmacology; D006801:Humans; D008124:Locomotion / Q000187:drug effects; D008297:Male; D008781:Methyltyrosines / Q000494:pharmacology; D010634:Phenobarbital / Q000494:pharmacology; D011398:Promethazine / Q000494:pharmacology; D051381:Rats; D012110:Reserpine / Q000494:pharmacology; D013239:Stereotyped Behavior / Q000187:drug effects; D013569:Synapses / Q000187:drug effects; D013997:Time Factors
D002395:Catecholamines; D008781:Methyltyrosines; D012110:Reserpine; D011398:Promethazine; D006220:Haloperidol; D001058:Apomorphine; D003975:Diazepam; D002746:Chlorpromazine; D010634:Phenobarbital